Abnormal distribution of Tc-99m iminodiphosphonate due to iron dextran therapy.
Hiltz
A
A
Department of Pharmaceutical Services, Victoria General Hospital, Halifax, Nova Scotia, Canada.
Iles
S E
SE
D000368:Aged; D000743:Anemia, Hemolytic / Q000188:drug therapy; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D006801:Humans; D007505:Iron-Dextran Complex / Q000627:therapeutic use*; D008297:Male; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D014018:Tissue Distribution
D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; C035003:technetium Tc 99m-imidodiphosphate; D007505:Iron-Dextran Complex